Literature DB >> 18343509

Neuropeptide Y receptor-specifically modulates human neutrophil function.

Sammy Bedoui1, Andreas Kromer, Thomas Gebhardt, Roland Jacobs, Kerstin Raber, Mirja Dimitrijevic, Jörn Heine, Stephan von Hörsten.   

Abstract

Despite a continuously growing body of evidence highlighting the role of NPY in the immune system, surprisingly little is known about its ability to alter human leukocyte function. We therefore set out to examine NPY receptor expression and functional effects of NPY in freshly isolated human neutrophils. Our results not only demonstrate for the first time the presence of specific NPY receptors on human neutrophils, but also unveil of how these receptors differentially modulate critical functions of neutrophils such as phagocytosis of bacteria as well as the release of reactive oxygen species.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18343509     DOI: 10.1016/j.jneuroim.2008.01.012

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  14 in total

Review 1.  NPY and stress 30 years later: the peripheral view.

Authors:  Dalay Hirsch; Zofia Zukowska
Journal:  Cell Mol Neurobiol       Date:  2012-01-24       Impact factor: 5.046

2.  Intracolonic Neuropeptide Y Y1 Receptor Inhibition Attenuates Intestinal Inflammation in Murine Colitis and Cytokine Release in IBD Biopsies.

Authors:  Bindu Chandrasekharan; Darra Boyer; Joshua A Owens; Alexandra A Wolfarth; Bejan J Saeedi; Tanvi Dhere; Heba Iskandar; Andrew S Neish
Journal:  Inflamm Bowel Dis       Date:  2022-03-30       Impact factor: 7.290

Review 3.  The homeostatic role of neuropeptide Y in immune function and its impact on mood and behaviour.

Authors:  A Farzi; F Reichmann; P Holzer
Journal:  Acta Physiol (Oxf)       Date:  2015-01-09       Impact factor: 6.311

4.  Innate immune properties of selected human neuropeptides against Moraxella catarrhalis and nontypeable Haemophilus influenzae.

Authors:  Daria Augustyniak; Adam Jankowski; Paweł Mackiewicz; Agnieszka Skowyra; Jan Gutowicz; Zuzanna Drulis-Kawa
Journal:  BMC Immunol       Date:  2012-05-02       Impact factor: 3.615

5.  Neuropeptide Y inhibits interleukin-1β-induced phagocytosis by microglial cells.

Authors:  Raquel Ferreira; Tiago Santos; Michelle Viegas; Luísa Cortes; Liliana Bernardino; Otília V Vieira; João O Malva
Journal:  J Neuroinflammation       Date:  2011-12-02       Impact factor: 8.322

Review 6.  Microbiota and gut neuropeptides: a dual action of antimicrobial activity and neuroimmune response.

Authors:  Julia Aresti Sanz; Sahar El Aidy
Journal:  Psychopharmacology (Berl)       Date:  2019-04-17       Impact factor: 4.530

7.  Pharmacological inhibition of NPY receptors illustrates dissociable features of experimental colitis in the mouse DSS model: Implications for preclinical evaluation of efficacy in an inflammatory bowel disease model.

Authors:  Henry H Ruiz; Stephanie Becker; Yu Bai; Luz A Cortes-Burgos; Melissa M Eckersdorff; Lynn E Macdonald; Susan D Croll
Journal:  PLoS One       Date:  2019-08-01       Impact factor: 3.240

Review 8.  Immune Dysfunction in Uremia 2020.

Authors:  Gerald Cohen
Journal:  Toxins (Basel)       Date:  2020-07-05       Impact factor: 4.546

Review 9.  Direct and indirect antimicrobial activities of neuropeptides and their therapeutic potential.

Authors:  Daria Augustyniak; Judyta Nowak; Fionnuala T Lundy
Journal:  Curr Protein Pept Sci       Date:  2012-12       Impact factor: 3.272

Review 10.  The Neuromodulation of the Intestinal Immune System and Its Relevance in Inflammatory Bowel Disease.

Authors:  Martina Di Giovangiulio; Simon Verheijden; Goele Bosmans; Nathalie Stakenborg; Guy E Boeckxstaens; Gianluca Matteoli
Journal:  Front Immunol       Date:  2015-11-20       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.